Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MESNA for B-cell lymphoma refractory: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where MESNA was used for B-cell lymphoma refractory.

Most Reported Side Effects for MESNA

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 707 14.5% 47 532
Pyrexia 352 7.2% 46 249
Off label use 299 6.1% 51 138
Cystitis haemorrhagic 294 6.0% 9 23
Disease progression 273 5.6% 151 9
Neutropenia 238 4.9% 36 96
Encephalopathy 226 4.6% 27 148
Vomiting 200 4.1% 36 120
Death 184 3.8% 184 13
Pancytopenia 179 3.7% 20 96
Diarrhoea 177 3.6% 35 110
Sepsis 173 3.5% 77 80
Bacterial infection 172 3.5% 151 23
Nausea 166 3.4% 20 81
Anaemia 163 3.3% 16 89

Other Indications for MESNA

Prophylaxis (566) Product used for unknown indication (554) Acute lymphocytic leukaemia (502) Infection prophylaxis (204) Diffuse large b-cell lymphoma (200) Non-hodgkin's lymphoma (113) B-cell lymphoma (91) Burkitt's lymphoma (88) Ewing's sarcoma (88) Neuroblastoma (85)

Other Drugs Used for B-cell lymphoma refractory

RITUXIMAB (103) OBINUTUZUMAB (84) CISPLATIN (53) ETOPOSIDE (49) DEXAMETHASONE (45) AXICABTAGENE CILOLEUCEL (44) CYCLOPHOSPHAMIDE (43) CYTARABINE (40) IBRUTINIB (39) LENALIDOMIDE (36)

Related Pages

MESNA Full Profile All B-cell lymphoma refractory Drugs MESNA Demographics MESNA Timeline